T-cell Therapy with CRISPR PD1-edited Tumor Infiltrating Lymphocytes for Patients with Metastatic Melanoma
NCT06783270
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Melanoma Metastatic
Interventions
BIOLOGICAL:
TIL therapy
Sponsor
Inge Marie Svane